In the fast-evolving world of pharmaceutical logistics, Good Distribution Practice (GDP) is the backbone of safe, effective medicine delivery. Surfact now tracks the vast majority of pharmaceutical shipments nationwide for leading industry players covering the majority of the market.
Why GDP matters in pharmaceutical distribution
GDP guidelines ensure that medicines are consistently stored, transported and handled under optimal conditions. For temperature-sensitive pharmaceuticals, even minor deviations can compromise product efficacy and patient safety. That's why GDP compliance is non-negotiable for manufacturers, distributors and logistics providers.
A market-leading solution
- ISO 17025 certified accuracy: independently certified for precision, delivering reliable, audit-ready data
- Optimized for pharma cold chain: designed specifically for pharmaceutical logistics
- Effortless deployment: place trackers inside packaging, on pallet level, or mount them in trucks
- Automated compliance reporting: instantly generate temperature compliance reports
- Easy integration with open APIs so your operations remain efficient and future-proof
Flexible tracking for every scenario
- Protect high-value, temperature-sensitive medicines inside primary packaging
- Monitor entire pallets for bulk shipments
- Track environmental conditions in transport vehicles, without complex installations
Trusted by Norway's key pharmaceutical players
Our commitment to Good Distribution Practice has made Surfact the go-to solution for Norway's leading pharmaceutical companies. By ensuring full temperature compliance, providing actionable insights and offering robust integration capabilities, we help our customers safeguard product integrity and patient health, while staying ahead of regulatory demands.
GDP compliance is more critical than ever. Every shipment should arrive safe, effective and fully compliant.